J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.
UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...
Shares of GSK PLC GSK inched up 0.94% to £14.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,557.81. GSK ...
The upcoming Chiefs-Eagles Super Bowl has added fuel to the fire of a popular NFL conspiracy involving the colors in the logo ...
The friendly whale might be just the design disruptor the artificial intelligence industry needs. The Chinese AI company DeepSeek is making major waves across the tech industry after rising to ...
GSK PLC closed 23.91% below its 52-week high of £18.24, which the company reached on May 16th.
Super Bowl LIX is fast approaching as the final four teams face off against each other this weekend. Many football fans will ...